Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.40822 | 55 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.30175 | 53 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.3087 | 53 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.1775 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.2533 | 53 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.47282 | 55 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.47437 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.28735 | 53 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.26079 | 52 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.2881 | 53 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.30422 | 53 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.27591 | 53 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.33529 | 54 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.30409 | 53 |